These four molecular subtypes are defined by the dominant expression of ASCL1 (SCLC-A), NEUROD1 (SCLC-N), POU2F3 (SCLC-P), or YAP1 (SCLC-Y). This evidence concerns the gene ASCL1 and small cell lung carcinoma.